… and therapeutic efficacy in a hamster model of SARS-CoV-2 … be quickly elicited during natural
SARS-CoV-2 infection or by … ab1 has potential for therapy and prophylaxis of SARS-CoV-2 …

… needs for COVID-19 therapy as no SARS-CoV-2-specific drugs … and therapeutic efficacy of
MW05/LALA on SARS-CoV-2 in … -based therapies for prophylactic and therapeutic treatment …

… Here, we demonstrate the in vitro antiviral activity and in vivo therapeutic efficacy of GS-…
antiviral activity in mice infected with SARS-CoV-2. Therapeutic GS-621763 significantly reduced …

… of US Food and Drug Administration (FDA)-approved therapeutic mAbs against BA.1 …
SARS-CoV-2 research 7,8,9 . In addition, using this model, we evaluated the therapeutic efficacy of …

… of antiviral therapies as we previously described 5 . Here we adopted this animal model for
evaluation of hACE2-Fc prophylactic and therapeutic efficacy against SARS-CoV-2 infection …

… It also showed therapeutic efficacy against SARS-CoV in a … that therapies with evidence for
benefit in SARS-CoV and MERS-CoV infections are more likely to benefit patients with SARS-…

… be targeted by therapeutic agents for treatment of SARS-CoV-2 … treatment, while oxygen
therapy is employed for intervention in … drugs/therapeutic agents and treatment for SARS-CoV-2 …

… recommended therapeutic agents, … therapeutic activity. The results of recent studies report
that hydroxychloroquine and convalescent plasma demonstrate no efficacy against SARS-CoV…

… ) and Middle East respiratory syndrome coronavirus (MERS-CoV) was … therapeutic efficacy,
but its safety profile allowed the initiation of drug repurposing research, including SARS-CoV-…

… we assessed the in vivo therapeutic activity of another neutralizing anti-SARS-CoV-2 monoclonal
antibody … 8), demonstrate improved therapeutic efficacy compared with wild-type IgG1. …